Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes

Clinical trial NCT00325429 · COMPLETED

Trial details

NCT number: NCT00325429
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2006-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.